Byoung-Moo Seo

Byoung-Moo Seo

Auto-generated profile, based on publicly available information

Byoung-Moo Seo

Department of Oral and Maxillofacial Surgery, Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2004 in The Lancet
Verified
Journal Article
Closed access
BSByoung-Moo Seo
Byoung-Moo Seo
MMMasako Miura
Masako Miura
SGStan Gronthos
Stan Gronthos
Mark BartoldMark Bartold
Mark Bartold
SBSara Batouli
Sara Batouli
SSSongtao Shi
Songtao Shi

1 March 2006 in Biomaterials
Verified
Journal Article
Closed access
KRKyong Su Rho
Kyong Su Rho
LJLim Jeong
Lim Jeong
GLGene Lee
Gene Lee
BSByoung-Moo Seo
Byoung-Moo Seo
YPYoon Jeong Park
Yoon Jeong Park
BMByung-Moo Min
Byung-Moo Min

1 April 2006 in Stem Cells
Verified
Journal Article
Open access
PDF file
MMMasako Miura
Masako Miura
YMYasuo Miura
Yasuo Miura
HPHesed M. Padilla-Nash
Hesed M. Padilla-Nash
AMAlfredo A. Molinolo
Alfredo A. Molinolo
BFBaojin Fu
Baojin Fu
SSSongtao Shi
Songtao Shi
Despite recent emerging evidence suggesting that cancer stem cells subsist in a variety of tumors, it is not yet fully elucidated whether postnatal stem cells are directly involved in tumorigenesis. We used murine bone marrow–derived mesenchymal stem cells (BMMSCs) as a model to test a hypothesis that tumorigenesis may originate from spontaneous mutation of stem cells. In this study, we demonstrated that murine BMMSCs, after numerous passages, obtained unlimited population doublings and proceeded to a malignant transformation state, resulting in fibrosarcoma formation in vivo. Transformed BMMSCs colonized to multiple organs when delivered systemically through the tail vein. Fibrosarcoma cells formed by transformed BMMSCs contained cancer progenitors, which were capable of generating colony clusters in vitro and fibrosarcoma in vivo by the second administration. The mechanism by which BMMSCs transformed to malignant cells was associated with accumulated chromosomal abnormalities, gradual elevation in telomerase activity, and increased c-myc expression. Moreover, BMMSCs and their transformed counterpart, fibrosarcoma-forming cells, demonstrated different sensitivity to anti-cancer drugs. BMMSCs/fibrosarcoma transformation system may provide an ideal system to elucidate the mechanism of how stem cells become cancer cells and to screen anti-sarcoma drugs.

1 November 2009 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
SKSu-Hwan Kim
Su-Hwan Kim
KKKyoung‐Hwa Kim
Kyoung‐Hwa Kim
BSByoung‐Moo Seo
Byoung‐Moo Seo
KKKi‐Tae Koo
Ki‐Tae Koo
Tae-Il KimTae-Il Kim
Tae-Il Kim
YLYong‐Moo Lee
Yong‐Moo Lee
Background: The present study was undertaken to evaluate the potential of periodontal ligament stem cells (PDLSCs) and bone marrow SCs (BMSCs) on alveolar bone regeneration in a canine peri‐implant defect model.Methods: Four adult, male beagle dogs were used in this study. Autologous BMSCs from the iliac crests and PDLSCs from extracted teeth were cultured. Three months after extraction, BMSC‐ and PDLSC‐loaded hydroxyapatite/β‐tricalcium phosphate (HA/TCP) (test groups) and cell‐free HA/TCP (control group) were implanted in three rectangular, saddle‐like peri‐implant defects, respectively. The left side of the mandible was initially prepared, and after 8 weeks, the right side was also prepared. The animals were sacrificed after an 8‐week healing period. Undecalcified ground sections were prepared. New bone formation and bone‐to‐implant contact (BIC) were measured histomorphometrically. BMSCs and PDLSCs were fluorescently labeled and traced.Results: Alveolar bone regeneration in surgically created peri‐implant saddle‐like defects was more effective in test groups than the control group. The BMSC group had the highest new bone formation (34.99% and 40.17% at healing times of 8 and 16 weeks, respectively) followed by the PDLSC group (31.90% and 36.51%) and control group (23.13% and 28.36%), respectively. Test groups exhibited a significantly higher new bone formation than the control group at 8 weeks, but the same was true for only the BMSC group at 16 weeks (P <0.05). Fluorescently labeled cells were identified adjacent to HA/TCP carriers and, partly, near connective tissues and osteoids.Conclusion: This study demonstrated the feasibility of using stem cell–mediated bone regeneration to treat peri‐implant defects.

1 December 2011 in Biomaterials
Verified
Journal Article
Closed access
JLJi-Hyun Lee
Ji-Hyun Lee
DLDong-Seol Lee
Dong-Seol Lee
HCHan-Wool Choung
Han-Wool Choung
WSWon-Jun Shon
Won-Jun Shon
BSByoung-Moo Seo
Byoung-Moo Seo
JPJoo-Cheol Park
Joo-Cheol Park

23 March 2012 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
JLJoo-Hee Lee
Joo-Hee Lee
SUSoyoun Um
Soyoun Um
JJJun-Hyeog Jang
Jun-Hyeog Jang
BSByoung Moo Seo
Byoung Moo Seo